Y-Intercept (HK)’s HEXO Corp. Common Shares HEXO Stock Holding History

Y-Intercept (HK)’s Portfolio HEXO Stock Details HEXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-878	Closed	-$79K	–	967
2021 Q1	$79K	Buy	+878	New	+$85.5K	0.02%	592

Other funds holding HEXO

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IIM

Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return

Y-Intercept (HK)'s HEXO Position: Q2 2021 in Review

Y-Intercept (HK) sold out of HEXO Corp. Common Shares (HEXO) in Q2 2021, closing a stake of 878 shares — an estimated $79K sold.

Y-Intercept (HK) first reported a position in HEXO in Q1 2021 and held it in 1 quarter. The position peaked at $79K in Q1 2021. 113 funds tracked by Wall St. Rank hold HEXO as of Q2 2021.

Y-Intercept (HK) reported no remaining HEXO Corp. Common Shares position as of Q2 2021 after selling out during the quarter.
Y-Intercept (HK) sold 878 HEXO Corp. Common Shares shares in Q2 2021, an estimated $79K.
Y-Intercept (HK) first reported a position in HEXO Corp. Common Shares in Q1 2021 and held it in 1 quarter.
Y-Intercept (HK)'s HEXO Corp. Common Shares position peaked at $79K in Q1 2021.
113 funds tracked by Wall St. Rank held HEXO Corp. Common Shares as of Q2 2021.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.